{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:44:51Z","timestamp":1759365891724,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.neurobiolaging.2019.05.012","type":"journal-article","created":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T11:19:40Z","timestamp":1558351180000},"page":"238.e19-238.e24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Novel presenilin 1 mutation (p.Thr-Pro116-117Ser-Thr) in a Spanish family with early-onset Alzheimer's disease"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1304-8137","authenticated-orcid":false,"given":"Jose Antonio","family":"Blanco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Rojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"Teller\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Angeles","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Uribe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib2","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/jnnp.2007.123026","article-title":"Ataxic variant of Alzheimer\u2019s disease caused by Pro117Ala PSEN1 mutation","volume":"78","author":"Anheim","year":"2007","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pcbi.1003440","article-title":"PredictSNP: robust and accurate consensus classifier for prediction of disease-related mutations","volume":"10","author":"Bendl","year":"2014","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/jmg.33.8.661","article-title":"No founder effect in three novel Alzheimer\u2019s disease families with APP 717 Val-->Ile mutation. Clerget-darpoux. French Alzheimer\u2019s Disease Study Group","volume":"33","author":"Campion","year":"1996","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40142-016-0086-1","article-title":"Genetic and epigenetic architecture of Alzheimer\u2019s dementia","volume":"4","author":"Cervera-Carles","year":"2016","journal-title":"Curr. Genet. Med. Rep."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib6","doi-asserted-by":"crossref","first-page":"e46688","DOI":"10.1371\/journal.pone.0046688","article-title":"Predicting the functional effect of amino acid substitutions and indels 7","volume":"7","author":"Choi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/nbdi.1998.0183","article-title":"Additive effects of PS1 and APP mutations on secretion of the 42- residue amyloid \u03b2-protein","volume":"5","author":"Citron","year":"1998","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib8","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/humu.22117","article-title":"Locus-specific mutation databases for neurodegenerative brain diseases","volume":"33","author":"Cruts","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/34910","article-title":"Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein","volume":"391","author":"De Strooper","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3233\/JAD-2004-6105","article-title":"A\u00a0novel highly pathogenic Alzheimer presenilin-1 mutation in codon 117 (Pro117Ser): comparison of clinical, neuropathological and cell culture phenotypes of Pro117Leu and Pro117Ser mutations","volume":"6","author":"Dowjat","year":"2004","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-017-1353-5","article-title":"Evaluation of in silico algorithms for use with ACMG\/AMP clinical variant interpretation guidelines","volume":"18","author":"Ghosh","year":"2017","journal-title":"Genome Biol."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib12","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3233\/JAD-2010-1292","article-title":"Clinical-genetic correlations in familial Alzheimer\u2019s disease caused by presenilin 1 mutations","volume":"19","author":"G\u00f3mez-Tortosa","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib13","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.neurobiolaging.2008.06.012","article-title":"Genetic screening of Alzheimer\u2019s disease genes in Iberian and African samples yields novel mutations in presenilins and APP","volume":"31","author":"Guerreiro","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-018-0392-9","article-title":"Discovery and validation of autosomal dominant Alzheimer\u2019s disease mutations","volume":"10","author":"Hsu","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/mp.2017.218","article-title":"Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease","volume":"23","author":"Hunter","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1468-1331.2004.00828.x","article-title":"A\u00a0novel mutation (Thr116Ile) in the presenilin 1 gene in a patient with early-onset Alzheimer\u2019s disease","volume":"11","author":"La Bella","year":"2004","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib17","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3233\/JAD-130746","article-title":"Presenilin-1 mutations in Alzheimer\u2019s disease: an update on genotype-phenotype relationships","volume":"37","author":"Larner","year":"2013","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib18","doi-asserted-by":"crossref","first-page":"35352","DOI":"10.1074\/jbc.M507217200","article-title":"A\u00a0nine-transmembrane domain topology for presenilin 1","volume":"280","author":"Laudon","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3940(00)01449-X","article-title":"Reduced antioxidant enzyme activity in brains of mice transgenic for human presenilin-1 with single or multiple mutations","volume":"292","author":"Leutner","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib20","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1086\/509900","article-title":"Mutations of presenilin genes in dilated cardiomyopathy and heart failure","volume":"79","author":"Li","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib21","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0002-9440(10)64688-3","article-title":"Amyloid angiopathy and variability in amyloid \u03b2 deposition is determined by mutation position in presenilin-1-linked Alzheimer\u2019s disease","volume":"158","author":"Mann","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00401-013-1177-7","article-title":"The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy","volume":"126","author":"McGeer","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1474-4422(12)70307-1","article-title":"Correspondence A presenilin 1 mutation in the fi rst case of Alzheimer\u2019s disease","volume":"12","author":"M\u00fcller","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib24","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"SIFT: predicting Amino acid changes that affect Protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/nar\/gkr407","article-title":"Predicting the functional impact of protein mutations: application to cancer genomics","volume":"39","author":"Reva","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib27","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1097\/00001756-199908020-00006","article-title":"A\u00a0presenilin-1 Thr116Asn substitution in a family with early-onset Alzheimer\u2019s disease","volume":"10","author":"Romero","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib28","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jalz.2014.06.005","article-title":"A\u00a0presenilin 1 mutation in the first case of Alzheimer\u2019s disease: revisited","volume":"10","author":"Rupp","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib29","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S1474-4422(16)30193-4","article-title":"Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer\u2019s disease: a case series","volume":"15","author":"Ryan","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/WNL.0000000000000596","article-title":"Symptom onset in autosomal dominant Alzheimer disease","volume":"83","author":"Ryman","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth.2890","article-title":"MutationTaster2: mutation prediction for the deep-sequencing age","volume":"11","author":"Schwarz","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib32","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib33","doi-asserted-by":"crossref","first-page":"E476","DOI":"10.1073\/pnas.1618657114","article-title":"Analysis of 138 pathogenic mutations in presenilin-1 on the in\u00a0vitro production of A\u03b242 and A\u03b240 peptides by \u03b3-secretase","volume":"114","author":"Sun","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib34","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00702-018-1850-z","article-title":"Neuropathology and biochemistry of early onset familial Alzheimer\u2019s disease caused by presenilin-1 missense mutation Thr116Asn","volume":"125","author":"Sutovsky","year":"2018","journal-title":"J.\u00a0Neural Transm. (Vienna)"},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mcn.2015.06.002","article-title":"Decrease in catalytic capacity of \u03b3-secretase can facilitate pathogenesis in sporadic and Familial Alzheimer\u2019s disease","volume":"67","author":"Svedru\u017ei\u0107","year":"2015","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib36","doi-asserted-by":"crossref","first-page":"10544","DOI":"10.1073\/pnas.1402171111","article-title":"Allosteric regulation of -secretase activity by a phenylimidazole-type -secretase modulator","volume":"111","author":"Takeo","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib37","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3233\/JAD-180829","article-title":"Abeta42\/Abeta40 ratios of presenilin 1 mutations correlate with clinical onset of Alzheimer\u2019s disease","volume":"66","author":"Tang","year":"2018","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00001756-199801260-00008","article-title":"A\u00a0novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer\u2019s disease and leads to death as early as the age of 28 years","volume":"9","author":"Wisniewski","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib39","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.neuron.2015.02.010","article-title":"Presenilin-1 knockin mice reveal loss-of-function mechanism for familial Alzheimer\u2019s disease","volume":"85","author":"Xia","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib40","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0014-4886(03)00384-4","article-title":"Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer\u2019s disease in Poland","volume":"184","author":"Zekanowski","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.05.012_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2047-9158-2-15","article-title":"Biological function of Presenilin and its role in AD pathogenesis","volume":"2","author":"Zhang","year":"2013","journal-title":"Transl. Neurodegener."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458019301654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458019301654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:33:17Z","timestamp":1759318397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458019301654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":41,"alternative-id":["S0197458019301654"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.05.012","relation":{},"ISSN":["0197-4580"],"issn-type":[{"type":"print","value":"0197-4580"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel presenilin 1 mutation (p.Thr-Pro116-117Ser-Thr) in a Spanish family with early-onset Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}